Melanoma resists chemotherapy through an adaptive mitochondrial response.

Saved in:
Bibliographic Details
Title: Melanoma resists chemotherapy through an adaptive mitochondrial response.
Authors: Zarei M; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA. Mehrdad.Zarei@case.edu.; Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, OH, Cleveland, USA. Mehrdad.Zarei@case.edu., Ali SA; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA., Loftus AW; Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, OH, Cleveland, USA., Nakazzi F; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA., Graor HJ; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA., Prajapati O; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA., Abul-Khoudoud SO; Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, OH, Cleveland, USA., Asara JM; Department of Medicine, Harvard Medical School, Boston, MA, USA., Wang R; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA.; Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, OH, Cleveland, USA., Winter JM; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA.; Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, OH, Cleveland, USA., Rothermel LD; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA. Luke.Rothermel@UHHospitals.org.; Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, OH, Cleveland, USA. Luke.Rothermel@UHHospitals.org.
Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2026 Mar 26; Vol. 45 (1). Date of Electronic Publication: 2026 Mar 26.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1756-9966
DOI:10.1186/s13046-026-03685-8